People and Business News — 6/22
People News
WCG has appointed Sam Srivastava as Chief Executive Officer; Robert VanHees as Chief Financial and Administrative Officer; and Paul Mancinelli, PhD, as Chief Technology Officer.
mdgroup has charged its new VP, Product Delivery, Mohamad (Mo) Merhi with doubling the development team, and appointed LaQuinta Jernigan to Chief Operating Officer.
Dotmatics announced the additions of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer.
AeroSafe Global announced Jessica Cao joined the company as Senior Vice President of Marketing.
Allucent, announced the appointment of Katy Moore as President of Clinical Pharmacology, Modeling and Simulation.
Walgreens announced several new hires including Kendal Whitlock as Head of Digital Optimization, RWE Clinical Trials; John Campbell as Head of Decentralized Clinical Trials; Liam Wood as Head of Product, RWE Clinical Trials, and Adam Samson as Head of Clinical Delivery Operations, RWE Clinical Trials.
Recognition
Vitalograph is celebrating 21 years as a clinical trials service provider.
mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.
For the seventh consecutive year, Celerion has been named recipient of the Life Science Leader and Clinical Leader’s CRO Leadership Awards in all five award categories.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
